1-4 of 4
Elisabeth G.E. de Vries
Close
Sort by
Journal Articles

In Vivo Treatment of AML Patients with High-Dose Simvastatin Inhibits Geranylgeranylation In AML Cells

Karen van der Weide, Susan D.P.W.M. de Jonge-Peeters, Gerwin A. Huls, MD, PhD, Rudolf S.N. Fehrmann, Jan J. Schuringa, PhD, Folkert Kuipers, PhD, Elisabeth G.E. de Vries, MD, PhD, Edo Vellenga, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3280.
https://doi.org/10.1182/blood.V116.21.3280.3280
Published: 2010
Journal Articles

Heterogeneity in Simvastatin-Induced Cytotoxicity in AML Is Related to Differential Ras-Isoprenylation, Rather Than to Blockade of Cholesterol Synthesis.

Karen van der Weide, Patrick M. Korthuis, Folkert Kuipers, Elisabeth G.E. de Vries, Edo Vellenga
Journal: Blood
Blood (2009) 114 (22): 1718.
https://doi.org/10.1182/blood.V114.22.1718.1718
Published: 2009
Journal Articles

High Expression of Multidrug Resistance-Associated Proteins Predicts Prognosis in Acute Lymphoblastic Leukemia in Children and Adults.

Sabine L.A. Plasschaert, M.D., Eveline S.J.M. de Bont, M.D. Ph.D., Marike Boezen, Ph.D., Dorina M. van der Kolk, Ph.D., Simon M.J.G. Daenen, M.D. Ph.D., Klaas Nico Faber, Ph.D., Willem A. Kamps, M.D. Ph.D., Elisabeth G.E. de Vries, M.D. Ph.D., Edo Vellenga, M.D. Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1178.
https://doi.org/10.1182/blood.V104.11.1178.1178
Published: 2004
Journal Articles

Selective Expression of a Number of ABC Transporter Genes in Normal CD34 + CD38 − Versus CD34 + CD38 − Cells, with a Reverse Pattern in a Subgroup of AML Patients.

Dorina M. van der Kolk, PhD, Susan D.P.W.M. Peeters, Gerald de Haan, PhD, Leonid Bystrykh, PhD, Elisabeth G.E. de Vries, PhD, MD, Edo Vellenga, PhD, MD.
Journal: Blood
Blood (2004) 104 (11): 4291.
https://doi.org/10.1182/blood.V104.11.4291.4291
Published: 2004